126 related articles for article (PubMed ID: 34311024)
1. p28-functionalized PLGA nanoparticles loaded with gefitinib reduce tumor burden and metastases formation on lung cancer.
Garizo AR; Castro F; Martins C; Almeida A; Dias TP; Fernardes F; Barrias CC; Bernardes N; Fialho AM; Sarmento B
J Control Release; 2021 Sep; 337():329-342. PubMed ID: 34311024
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte membrane-camouflaged gefitinib/albumin nanoparticles for tumor imaging and targeted therapy against lung cancer.
Wen Q; Zhang Y; Muluh TA; Xiong K; Wang B; Lu Y; Wu Z; Liu Y; Shi H; Xiao S; Fu S
Int J Biol Macromol; 2021 Dec; 193(Pt A):228-237. PubMed ID: 34688683
[TBL] [Abstract][Full Text] [Related]
3. Gefitinib and curcumin-loaded nanoparticles enhance cell apoptosis in human oral cancer SAS cells in vitro and inhibit SAS cell xenografted tumor in vivo.
Lai KC; Chueh FS; Hsiao YT; Cheng ZY; Lien JC; Liu KC; Peng SF; Chung JG
Toxicol Appl Pharmacol; 2019 Nov; 382():114734. PubMed ID: 31470033
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo antitumor effect of gefitinib nanoparticles on human lung cancer.
Ni XL; Chen LX; Zhang H; Yang B; Xu S; Wu M; Liu J; Yang LL; Chen Y; Fu SZ; Wu JB
Drug Deliv; 2017 Nov; 24(1):1501-1512. PubMed ID: 28961023
[TBL] [Abstract][Full Text] [Related]
5. Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells.
Huang X; Huang J; Leng D; Yang S; Yao Q; Sun J; Hu J
World J Surg Oncol; 2017 Aug; 15(1):167. PubMed ID: 28854941
[TBL] [Abstract][Full Text] [Related]
6. Delivery of gefitinib loaded nanoparticles for effectively inhibiting prostate cancer progression.
Xiong Z; Tong T; Xie Z; Yu S; Zhuang R; Jia Q; Peng S; Li B; Xie J; Li K; Wu J; Huang H
Biomater Sci; 2024 Jan; 12(3):650-659. PubMed ID: 38168678
[TBL] [Abstract][Full Text] [Related]
7. A synergistic approach for management of lung carcinoma through folic acid functionalized co-therapy of capsaicin and gefitinib nanoparticles: Enhanced apoptosis and metalloproteinase-9 down-regulation.
Parashar P; Tripathi CB; Arya M; Kanoujia J; Singh M; Yadav A; Kaithwas G; Saraf SA
Phytomedicine; 2019 Feb; 53():107-123. PubMed ID: 30668390
[TBL] [Abstract][Full Text] [Related]
8. Strategy to enhance lung cancer treatment by five essential elements: inhalation delivery, nanotechnology, tumor-receptor targeting, chemo- and gene therapy.
Garbuzenko OB; Kuzmov A; Taratula O; Pine SR; Minko T
Theranostics; 2019; 9(26):8362-8376. PubMed ID: 31754402
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles targeting Sialyl-Tn for efficient tyrosine kinase inhibitor delivery in gastric cancer.
Diniz F; Lamas S; Osório H; Aguiar P; Freitas D; Gärtner F; Sarmento B; Reis CA; Gomes J
Acta Biomater; 2023 Oct; 170():142-154. PubMed ID: 37586448
[TBL] [Abstract][Full Text] [Related]
10. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
[TBL] [Abstract][Full Text] [Related]
11. EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells.
Sugita S; Ito K; Yamashiro Y; Moriya S; Che XF; Yokoyama T; Hiramoto M; Miyazawa K
Biochem Biophys Res Commun; 2015 May; 461(1):28-34. PubMed ID: 25858318
[TBL] [Abstract][Full Text] [Related]
12. Mucin-1 conjugated polyamidoamine-based nanoparticles for image-guided delivery of gefitinib to breast cancer.
Nabi PN; Vahidfar N; Tohidkia MR; Hamidi AA; Omidi Y; Aghanejad A
Int J Biol Macromol; 2021 Mar; 174():185-197. PubMed ID: 33516855
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine enhances gefitinib cytotoxicity in gefitinib-resistant nonsmall cell lung cancer cells.
Tang MC; Wu MY; Hwang MH; Chang YT; Huang HJ; Lin AM; Yang JC
PLoS One; 2015; 10(3):e0119135. PubMed ID: 25807554
[TBL] [Abstract][Full Text] [Related]
14. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
Wang X; Cheng R; Zhong Z
Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
[TBL] [Abstract][Full Text] [Related]
15. Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in
Noronha V; Patil VM; Joshi A; Menon N; Chougule A; Mahajan A; Janu A; Purandare N; Kumar R; More S; Goud S; Kadam N; Daware N; Bhattacharjee A; Shah S; Yadav A; Trivedi V; Behel V; Dutt A; Banavali SD; Prabhash K
J Clin Oncol; 2020 Jan; 38(2):124-136. PubMed ID: 31411950
[TBL] [Abstract][Full Text] [Related]
16. Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination.
Jia L; Gorman GS; Coward LU; Noker PE; McCormick D; Horn TL; Harder JB; Muzzio M; Prabhakar B; Ganesh B; Das Gupta TK; Beattie CW
Cancer Chemother Pharmacol; 2011 Aug; 68(2):513-24. PubMed ID: 21085965
[TBL] [Abstract][Full Text] [Related]
17. Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors.
Dal Bello MG; Alama A; Barletta G; Coco S; Truini A; Vanni I; Boccardo S; Genova C; Rijavec E; Biello F; Bottoni G; Sambuceti G; Grossi F
Int J Cancer; 2015 Dec; 137(12):2947-58. PubMed ID: 26089022
[TBL] [Abstract][Full Text] [Related]
18. Anticancer Actions of Azurin and Its Derived Peptide p28.
Huang F; Shu Q; Qin Z; Tian J; Su Z; Huang Y; Gao M
Protein J; 2020 Apr; 39(2):182-189. PubMed ID: 32180097
[TBL] [Abstract][Full Text] [Related]
19. Preparation and evaluation of inhalable dry powder containing glucosamine-conjugated gefitinib SLNs for lung cancer therapy.
Satari N; Taymouri S; Varshosaz J; Rostami M; Mirian M
Drug Dev Ind Pharm; 2020 Aug; 46(8):1265-1277. PubMed ID: 32594775
[TBL] [Abstract][Full Text] [Related]
20. Chitosan nanoparticles as a smart nanocarrier for gefitinib for tackling lung cancer: Design of experiment and in vitro cytotoxicity study.
Amin H; Amin MA; Osman SK; Mohammed AM; Zayed G
Int J Biol Macromol; 2023 Aug; 246():125638. PubMed ID: 37392910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
